Lifesci Acquisition II Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $75M
- Underwriters
- Focus
- Healthcare, Biopharmaceuticals
- SEC Filings
- 1819113
- Public Embarc Page
- https://embarc.com/capital/spac/1819113/LSAQ/lifesci-acquisition
- IPO Ticker
- LSAQ
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive OfficerAndrew McDonald
- Chief Operating OfficerMichael Rice
- Chief Financial OfficerDavid Dobkin
- DirectorThomas Wynn
- DirectorThomas Mathers
- DirectorGraham Walmsley
- DirectorElizabeth Barrett
- DirectorScott Janssen
Target Information
Information on the SPAC target for merger.
- Company
- Science 37
- Presentation
- Investor Presentation (SEC) on 2021-07-16
- New Ticker
- SNCE
- Description
- Science 37 is the "developer of the Decentralized Clinical Trial Operating System, which can enable significantly faster enrollment, retain patients at a meaningfully higher rate, and achieve higher enrollment among diverse patient populations."